Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Synapsins × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Cisplatin 889 Cyclophosphamide 840 Carboplatin 834 Radiotherapy 780 Bevacizumab 737 Gemcitabine 707 pembrolizumab 657 Docetaxel 653 Paclitaxel 645 Oxaliplatin 610 Capecitabine 569 Fluorouracil 512 Rituximab 497 Nivolumab 438 Dexamethasone 431 Etoposide 409 Doxorubicin 398 Irinotecan 392 Leucovorin 338 Drug Therapy 336 Cytarabine 301 Cetuximab 294 Lenalidomide 288 Trastuzumab 281 Pemetrexed 279 durvalumab 262 Filgrastim 249 Magnetic Resonance Spectroscopy 239 Prednisone 237 Temozolomide 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡